Follicum is a biotech company focused on the discovery and development of peptide-based drugs. The primary focus is in hair growth stimulation, where Follicum has obtained very promising results with FOL-005 in a recently completed clinical trial. In diabetes, the drug candidate FOL-014 has demonstrated an increase in insulin release in pre-clinical models. The company was founded in 2011, and is based in Lund, Sweden. Follicum is listed on the Swedish small cap exchange Aktietorget since 2014. www.follicum.com.

Quotes for Follicum AB

Right Now

+/-
%
0,00%
Latest
High
Low
Volume
0
Turnover (SEK)
0
Value (MSEK)
129,7

Board

CEO

  • Jan Alenfall

Chairman Of The Board

  • Gun-Britt Fransson

Board

  • Lars Bruzelius
  • Anna Hultgårdh Nilsson
  • Jonas Edelswärd
  • Gun-Britt Fransson
  • Alejandra Mörk

Videos

Largest Owner

Name Capital % Votes % Date
Swedish Growth Fund 14,91 14,91 2018-06-30
Avanza Pension 9,46 9,46 2018-06-30
Mats Lundberg 3,13 3,13 2018-06-30
Kudu AB 2,46 2,46 2018-06-30
Stiftelsen Akademihemman 2,13 2,13 2018-06-30
Nordnet Pensionsförsäkring 1,78 1,78 2018-06-30
Atherioco AB 1,72 1,72 2018-06-30
Tibia Konsult AB 1,68 1,68 2018-06-30
Brushamn Invest AB 1,54 1,54 2018-06-30
Thomas Eldered 1,43 1,43 2018-06-30
** Holdings by Modular Finance AB. Compiled and processed data from various sources, including Euroclear, Morningstar and the Swedish Financial Supervisory Authority.

Insider trading

Key Numbers

*Compiled data from Inquiry Financial